CSIR launches India’s first anti diabetic ayurvedic drug BGR -34

Posted on:28 Jun 2016 11:06:20

CSIR launches India’s first anti diabetic ayurvedic drug BGR -34
28 June 2016 Current Affairs: The Council for Scientific and Industrial Research (CSIR) has launched BGR-34, an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus. 

The anti-diabetic ayurvedic drug BGR-34 has been jointly developedby National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP).

BGR-34 :  BGR-34 works by controlling blood sugar and limiting the harmful effects and toxicity of other drugs. It contains 34 identified active phyto-constitutes from herbal resources. It has been economically priced at 5 rupees per tablet as compared to latest DPP4 inhibitors globally.

Council of Scientific and Industrial Research (CSIR) :  CSIR is an autonomous body and the largest research and development (R&D) organisation in India. It was established in 1942. It operates as an autonomous body registered under the Registration of Societies Act of 1860.

 It is mainly funded by the Union Ministry of Science and Technology. CSIR’s R&D activities include aerospace engineering, ocean sciences, structural engineering, metallurgy, life sciences, chemicals, mining, food, petroleum, leather, and environment.


Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs May 2017

22 MAY
NEWS
20 MAY
NEWS
19 MAY
NEWS
18 MAY
NEWS

Current Affairs April 2017

29 APRIL
NEWS
28 APRIL
NEWS
27 APRIL
NEWS
26 APRIL
NEWS

Current Affairs March 2017

31 MARCH
NEWS
30 MARCH
NEWS
29 MARCH
NEWS
28 MARCH
NEWS